Reports
Sale
Asia Pacific Stem Cell Assay Market Size, Share, Growth: By Cell Type: Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent; By Type: Viability /Cytotoxicity Assays, Isolation & Purification Assays, Others; By Product & Service; By Treatment; By Application; By End User; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Asia Pacific Stem Cell Assay Market Outlook
The global stem cell assay market size was valued at USD 6.4 billion in 2023, with Asia Pacific holding a significant market share. The market is driven by the rising emphasis on stem cell research. It is expected to grow at a CAGR of 13.18% during the forecast period of 2024-2032, with the values likely to attain USD 19.4 billion by 2032.
Key Takeaways
- In February 2023 , a study revealed that chronic diseases are highly prevalent in China among older adults, with the data reporting the national prevalence of any chronic disease to be 81.1% in people aged 60 and older. The growing chronic disease burden and aging population in the Asia Pacific region directly impact the market demand for stem cell assays.
- The rising investment in stem cell manufacturing facilities from both private and public sectors is expected to elevate the Asia Pacific stem cell assay market value. In May 2023 , StemCures announced an investment amounting to USD 54 million in setting up India’s largest stem cell manufacturing lab in Telangana.
- Several countries in the Asia Pacific region are actively engaged in clinical studies to evaluate the efficacy and safety of therapeutic stem cell products. This rapid expansion of stem cell therapy clinical trials is poised to augment the market share.
Asia Pacific Stem Cell Assay Market Analysis
Stem cell assays are widely utilized to assess the characteristics, behavior, and properties of stem cells. They enable the researchers to study various aspects of stem cell biology, such as proliferation, differentiation, and viability. Several countries in the Asia Pacific region are actively engaged in clinical studies to evaluate the efficacy and safety of stem cell therapies. This rapid expansion of clinical research directly impacts the demand for this laboratory technique to validate certain attributes of therapeutic stem cell products and thus, significantly contributes to the Asia Pacific stem cell assay market growth.
In Asia Pacific, the prevalence of chronic diseases like cancer, diabetes, and cardiovascular disorders is witnessing a sharp increase. In February 2023 , a study published in the Journal of the American Medical Directors Association revealed that chronic diseases are highly prevalent in China among older adults, with the data reporting the national prevalence of any chronic disease to be 81.1% in people aged 60 and older. The prevalence rate peaked at 80 to 84 years old, indicating about 87.2% of individuals affected by some chronic health condition. Since stem cell research has the potential to develop novel treatments, the demand for stem cell assays to evaluate drug properties is likely to rise with the growing chronic disease burden and aging population in the region.
One of the major Asia Pacific stem cell assay market trends is the rising investment in stem cell manufacturing facilities from both private as well as public sectors. In May 2023 , StemCures, a stem cell treatment provider based in the United States announced an investment amounting to USD 54 million in setting up India’s largest stem cell manufacturing lab in Telangana (a southern state). Leveraging the latest technology and expertise, the proposed lab aims to develop high-quality and affordable stem cell products for the treatment of various medical conditions. Such substantial investment in stem cell facilities to boost research efforts and stimulate innovation in the stem cell field is expected to elevate the market value.
The growing demand for regenerative medicine, including stem cell therapies, is also influencing the market dynamics. Further, the rise in strategic collaborations among academic institutions, research organizations, and pharmaceutical companies to translate stem cell research into clinical applications is bolstering the demand for stem assays, thereby supporting market growth.
Asia Pacific Stem Cell Assay Market Segmentation
The report offers a detailed analysis of the market based on the following segments:
| Market Breakup | Categories |
| Cell Type | Adult Stem Cells, Human Embryonic Stem Cells, Pluripotent |
| Type | Viability/Cytotoxicity Assays, Isolation & Purification Assays, Cell Identification Assays, Proliferation Assays, Differentiation Assays, Function Assays, Apoptosis Assays, Others |
| Product & Service | Flow Cytometers, Cell Imaging & Analysis Systems, Microelectrode Arrays, Automated Cell Counters, Kits |
| Treatment | Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy, Syngeneic Stem Cell Therapy |
| Application | Regenerative Medicine and Therapy Development, Drug Discovery and Development, Clinical Research, Others |
| End User | Biopharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others |
| Countries | China, Japan, India, ASEAN, and Australia, Others |
Asia Pacific Stem Cell Assay Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Thermo Fisher Scientific
- PerkinElmer
- Stemcell Technologies
- Merck
- Bio-Rad Laboratories
- Agilent Technologies
- Promega
- Bio-Techne
- Cell Biolabs
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Cell Type |
|
| Breakup by Type |
|
| Breakup by Product & Service |
|
| Breakup by Treatment |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Asia Pacific Stem Cell Assay Market Overview
3.1 Asia Pacific Stem Cell Assay Market Historical Value (2017-2023)
3.2 Asia Pacific Stem Cell Assay Market Forecast Value (2024-2032)
4 Asia Pacific Stem Cell Assay Market Landscape*
4.1 Asia Pacific Stem Cell Assay: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Asia Pacific Stem Cell Assay: Product Landscape
4.2.1 Analysis by Product
4.2.2 Analysis by Cell Type
4.2.3 Analysis by Treatment
5 Asia Pacific Stem Cell Assay Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Asia Pacific Stem Cell Assay Market Segmentation (2017-2032)
6.1 Asia Pacific Stem Cell Assay Market (2017-2032) by Cell Type
6.1.1 Market Overview
6.1.2 Adult Stem Cells
6.1.3 Human Embryonic Stem Cells
6.1.4 Pluripotent
6.2 Asia Pacific Stem Cell Assay Market (2017-2032) by Type
6.2.1 Market Overview
6.2.2 Viability /Cytotoxicity Assays
6.2.3 Isolation & Purification Assays
6.2.4 Cell Identification Assays
6.2.5 Proliferation Assays
6.2.6 Differentiation Assays
6.2.7 Function Assays
6.2.8 Apoptosis Assays
6.2.9 Others
6.3 Asia Pacific Stem Cell Assay Market (2017-2032) by Product & Service
6.3.1 Market Overview
6.3.2 Flow Cytometers
6.3.3 Cell Imaging & Analysis Systems
6.3.4 Microelectrode Arrays
6.3.5 Automated Cell Counters
6.3.6 Kits
6.4 Asia Pacific Stem Cell Assay Market (2017-2032) by Treatment
6.4.1 Market Overview
6.4.2 Allogeneic Stem Cell Therapy
6.4.3 Autologic Stem Cell Therapy
6.4.4 Syngeneic Stem Cell Therapy
6.5 Asia Pacific Stem Cell Assay Market (2017-2032) by Application
6.5.1 Market Overview
6.5.2 Regenerative Medicine &Therapy Development
6.5.3 Drug Discovery & Development
6.5.4 Clinical Research
6.5.5 Others
6.6 Asia Pacific Stem Cell Assay Market (2017-2032) by End User
6.6.1 Market Overview
6.6.2 Biopharmaceutical & Biotechnology Companies
6.6.3 Academic & Research Institutes
6.6.4 Others
6.7 Asia Pacific Stem Cell Assay Market (2017-2032) by Countries
6.7.1 Market Overview
6.7.2 China
6.7.3 Japan
6.7.4 ASEAN
6.7.5 Australia
6.7.6 India
6.7.7 Others
7 China of Stem Cell Assay Market (2017-2032)
7.1 China Stem Cell Assay Market (2017-2032) by Cell Type
7.1.1 Market Overview
7.1.2 Adult Stem Cells
7.1.3 Human Embryonic Stem Cells
7.1.4 Pluripotent
7.2 China Stem Cell Assay Market (2017-2032) by Type
7.2.1 Market Overview
7.2.2 Viability /Cytotoxicity Assays
7.2.3 Isolation & Purification Assays
7.2.4 Cell Identification Assays
7.2.5 Proliferation Assays
7.2.6 Differentiation Assays
7.2.7 Function Assays
7.2.8 Apoptosis Assays
7.2.9 Others
7.3 China Stem Cell Assay Market (2017-2032) by Product & Service
7.3.1 Market Overview
7.3.2 Flow Cytometers
7.3.3 Cell Imaging & Analysis Systems
7.3.4 Microelectrode Arrays
7.3.5 Automated Cell Counters
7.3.6 Kits
7.4 China Stem Cell Assay Market (2017-2032) by Treatment
7.4.1 Market Overview
7.4.2 Allogeneic Stem Cell Therapy
7.4.3 Autologic Stem Cell Therapy
7.4.4 Syngeneic Stem Cell Therapy
7.5 China Stem Cell Assay Market (2017-2032) by End User
7.5.1 Market Overview
7.5.2 Biopharmaceutical & Biotechnology Companies
7.5.3 Academic & Research Institutes
7.5.4 Others
7.6 China Stem Cell Assay Market (2017-2032) by Application
7.6.1 Market Overview
7.6.2 Regenerative Medicine & Therapy Development
7.6.3 Drug Discovery & Development
7.6.4 Clinical Research
7.6.5 Others
8 Japan Stem Cell Assay Market (2017-2032)
8.1 Japan Stem Cell Assay Market (2017-2032) by Cell Type
8.1.1 Market Overview
8.1.2 Adult Stem Cells
8.1.3 Human Embryonic Stem Cells
8.1.4 Pluripotent
8.2 Japan Stem Cell Assay Market (2017-2032) by Type
8.2.1 Market Overview
8.2.2 Viability /Cytotoxicity Assays
8.2.3 Isolation & Purification Assays
8.2.4 Cell Identification Assays
8.2.5 Proliferation Assays
8.2.6 Differentiation Assays
8.2.7 Function Assays
8.2.8 Apoptosis Assays
8.2.9 Others
8.3 Japan Stem Cell Assay Market (2017-2032) by Product & Service
8.3.1 Market Overview
8.3.2 Flow Cytometers
8.3.3 Cell Imaging & Analysis Systems
8.3.4 Microelectrode Arrays
8.3.5 Automated Cell Counters
8.3.6 Kits
8.4 Japan Stem Cell Assay Market (2017-2032) by Treatment
8.4.1 Market Overview
8.4.2 Allogeneic Stem Cell Therapy
8.4.3 Autologic Stem Cell Therapy
8.4.4 Syngeneic Stem Cell Therapy
8.5 Japan Stem Cell Assay Market (2017-2032) by End User
8.5.1 Market Overview
8.5.2 Biopharmaceutical & Biotechnology Companies
8.5.3 Academic & Research Institutes
8.5.4 Others
8.6 Japan Stem Cell Assay Market (2017-2032) by Application
8.6.1 Market Overview
8.6.2 Regenerative Medicine &Therapy Development
8.6.3 Drug Discovery & Development
8.6.4 Clinical Research
9 ASEAN Stem Cell Assay Market (2017-2032)
9.1 ASEAN Stem Cell Assay Market (2017-2032) by Cell Type
9.1.1 Market Overview
9.1.2 Adult Stem Cells
9.1.3 Human Embryonic Stem Cells
9.1.4 Pluripotent
9.2 ASEAN Stem Cell Assay Market (2017-2032) by Type
9.2.1 Market Overview
9.2.2 Viability /Cytotoxicity Assays
9.2.3 Isolation & Purification Assays
9.2.4 Cell Identification Assays
9.2.5 Proliferation Assays
9.2.6 Differentiation Assays
9.2.7 Function Assays
9.2.8 Apoptosis Assays
9.2.9 Others
9.3 ASEAN Stem Cell Assay Market (2017-2032) by Product & Service
9.3.1 Market Overview
9.3.2 Flow Cytometers
9.3.3 Cell Imaging & Analysis Systems
9.3.4 Microelectrode Arrays
9.3.5 Automated Cell Counters
9.3.6 Kits
9.4 ASEAN Stem Cell Assay Market (2017-2032) by Treatment
9.4.1 Market Overview
9.4.2 Allogeneic Stem Cell Therapy
9.4.3 Autologic Stem Cell Therapy
9.4.4 Syngeneic Stem Cell Therapy
9.5 ASEAN Stem Cell Assay Market (2017-2032) by End User
9.5.1 Market Overview
9.5.2 Biopharmaceutical & Biotechnology Companies
9.5.3 Academic & Research Institutes
9.5.4 Others
9.6 ASEAN Stem Cell Assay Market (2017-2032) by Application
9.6.1 Market Overview
9.6.2 Regenerative Medicine &Therapy Development
9.6.3 Drug Discovery & Development
9.6.4 Clinical Research
9.6.5 Others
10 Australia Stem Cell Assay Market (2017-2032)
10.1 Australia Stem Cell Assay Market (2017-2032) by Cell Type
10.1.1 Market Overview
10.1.2 Adult Stem Cells
10.1.3 Human Embryonic Stem Cells
10.1.4 Pluripotent
10.2 Australia Stem Cell Assay Market (2017-2032) by Type
10.2.1 Market Overview
10.2.2 Viability /Cytotoxicity Assays
10.2.3 Isolation & Purification Assays
10.2.4 Cell Identification Assays
10.2.5 Proliferation Assays
10.2.6 Differentiation Assays
10.2.7 Function Assays
10.2.8 Apoptosis Assays
10.2.9 Others
10.3 Australia Stem Cell Assay Market (2017-2032) by Product & Service
10.3.1 Market Overview
10.3.2 Flow Cytometers
10.3.3 Cell Imaging & Analysis Systems
10.3.4 Microelectrode Arrays
10.3.5 Automated Cell Counters
10.3.6 Kits
10.4 Australia Stem Cell Assay Market (2017-2032) by Treatment
10.4.1 Market Overview
10.4.2 Allogeneic Stem Cell Therapy
10.4.3 Autologic Stem Cell Therapy
10.4.4 Syngeneic Stem Cell Therapy
10.5 Australia Stem Cell Assay Market (2017-2032) by End User
10.5.1 Market Overview
10.5.2 Biopharmaceutical & Biotechnology Companies
10.5.3 Academic & Research Institutes
10.5.4 Others
10.6 Australia Stem Cell Assay Market (2017-2032) by Application
10.6.1 Market Overview
10.6.2 Regenerative Medicine &Therapy Development
10.6.3 Drug Discovery & Development
10.6.4 Clinical Research
10.6.5 Others
11 India Stem Cell Assay Market (2017-2032)
11.1 India Stem Cell Assay Market (2017-2032) by Cell Type
11.1.1 Market Overview
11.1.2 Adult Stem Cells
11.1.3 Human Embryonic Stem Cells
11.1.4 Pluripotent
11.2 India Stem Cell Assay Market (2017-2032) by Type
11.2.1 Market Overview
11.2.2 Viability /Cytotoxicity Assays
11.2.3 Isolation & Purification Assays
11.2.4 Cell Identification Assays
11.2.5 Proliferation Assays
11.2.6 Differentiation Assays
11.2.7 Function Assays
11.2.8 Apoptosis Assays
11.2.9 Others
11.3 India Stem Cell Assay Market (2017-2032) by Product & Service
11.3.1 Market Overview
11.3.2 Flow Cytometers
11.3.3 Cell Imaging & Analysis Systems
11.3.4 Microelectrode Arrays
11.3.5 Automated Cell Counters
11.3.6 Kits
11.4 India Stem Cell Assay Market (2017-2032) by Treatment
11.4.1 Market Overview
11.4.2 Allogeneic Stem Cell Therapy
11.4.3 Autologic Stem Cell Therapy
11.4.4 Syngeneic Stem Cell Therapy
11.5 India Stem Cell Assay Market (2017-2032) by End User
11.5.1 Market Overview
11.5.2 Biopharmaceutical & Biotechnology Companies
11.5.3 Academic & Research Institutes
11.5.4 Others
11.6 India Stem Cell Assay Market (2017-2032) by Application
11.6.1 Market Overview
11.6.2 Regenerative Medicine &Therapy Development
11.6.3 Drug Discovery & Development
11.6.4 Clinical Research
11.6.5 Others
12 Regulatory Framework
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share by Top 5 Companies
16.2 Thermo Fisher Scientific
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 PerkinElmer
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Stemcell Technologies
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Merck
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 Bio-Rad Laboratories
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Agilent Technologies
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Promega
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 Bio-Techne
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
16.10 Cell Biolabs
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisitions
16.10.5 Certifications
17 Asia Pacific Stem Cell Assay Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The Asia Pacific stem cell assay market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 13.18% during the forecast period of 2024-2032 and is likely to reach a market value of USD 19.4 billion by 2032.
The rising emphasis on stem cell research and the increasing prevalence of chronic diseases are fuelling the demand for the market.
One of the significant trends in the market is the rising investment in stem cell manufacturing facilities from both private and public sectors. In May 2023 , StemCures announced an investment amounting to USD 54 million in setting up India’s largest stem cell manufacturing lab in Telangana.
The market breakup by cell type includes adult stem cells, human embryonic stem cells, and pluripotent.
By type, the market is divided into viability/cytotoxicity assays, isolation and purification assays, cell identification assays, proliferation assays, differentiation assays, function assays, and apoptosis assays, among others.
Based on the product and services, the market is segmented into flow cytometers, cell imaging & analysis systems, microelectrode arrays, automated cell counters, and kits.
Treatments available in the market include allogeneic stem cell therapy, autologous stem cell therapy, and syngeneic stem cell therapy.
Major application areas include regenerative medicine and therapy development, drug discovery and development, along with clinical research, among others.
End users of the market are biopharmaceutical and biotechnology companies, academic and research institutes, among others.
The market segmentation by countries includes China, Japan, India, ASEAN, and Australia, among others.
The key players in the market are Thermo Fisher Scientific, PerkinElmer, Stemcell Technologies, Merck, Bio-Rad Laboratories, Agilent Technologies, Promega, Bio-Techne, and Cell Biolabs.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2639
$2399
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 4399
$3999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 5829
$5299
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 6929
$6299
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER